The results showed that miR-200c expression was decreased, and ZEB1, the potent target of miR-200c was increased in all 5 primary resistant NSCLC cell lines, compared with PC9 (Figure 1B, 1C). The gene discussed is ZEB1; the disease is non-small cell lung carcinoma.